These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2726986)

  • 1. [Characterization of drug absorption from the gastrointestinal tract with the use of numeric deconvolution].
    Gröning R; Heun G
    Pharm Acta Helv; 1989; 64(3):71-5. PubMed ID: 2726986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies.
    Yu Z; Schwartz JB; Sugita ET; Foehl HC
    Biopharm Drug Dispos; 1996 Aug; 17(6):521-40. PubMed ID: 8866043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
    Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
    Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs.
    Pithavala YK; Soria I; Zimmerman CL
    Drug Metab Dispos; 1997 Nov; 25(11):1260-5. PubMed ID: 9351902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal absorption of drugs.
    Kararli TT
    Crit Rev Ther Drug Carrier Syst; 1989; 6(1):39-86. PubMed ID: 2665948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational prediction of oral drug absorption based on absorption rate constants in humans.
    Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M
    J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal permeability and its relevance for absorption and elimination.
    Lennernäs H
    Xenobiotica; 2007; 37(10-11):1015-51. PubMed ID: 17968735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
    Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions.
    Andersson KE
    Scand J Infect Dis Suppl; 1981; 26():60-7. PubMed ID: 6941457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling and Monte Carlo simulations in oral drug absorption.
    Dokoumetzidis A; Kosmidis K; Argyrakis P; Macheras P
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):200-5. PubMed ID: 15733215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of piretanide absorption from the gastrointestinal tract.
    Brockmeier D; Grigoleit HG; Heptner H; Meyer BH
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):731-9. PubMed ID: 3807474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gastrointestinal drug absorption in cynomolgus monkeys.
    Takahashi M; Washio T; Suzuki N; Igeta K; Fujii Y; Hayashi M; Shirasaka Y; Yamashita S
    Mol Pharm; 2008; 5(2):340-8. PubMed ID: 18247527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deconvolution at steady state: determination of gastrointestinal bioavailability of sustained release theophylline.
    Veng-Pedersen P; Miller R
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):233-7. PubMed ID: 3596848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
    Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
    Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiological model for the estimation of the fraction dose absorbed in humans.
    Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
    J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.